Medicare Enrolled

Dr. Marina Strizhevsky, DO

Internal Medicine · Lyndhurst, NJ
Practice pattern: Clinical Cardiology — Primarily office-based clinical cardiology
Low-engagement
612 RUTHERFORD AVE, Lyndhurst, NJ 07071
2014600063
In practice since 2008 (17 years)
NPI: 1235386574 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Strizhevsky from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Strizhevsky? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Strizhevsky

Dr. Marina Strizhevsky is an internal medicine specialist in Lyndhurst, NJ, with 17 years of NPI registration. Based on federal Medicare data, Dr. Strizhevsky performed 565 Medicare services across 330 unique beneficiaries.

Between the years covered by Open Payments, Dr. Strizhevsky received a total of $9,628 from 44 pharmaceutical and/or device companies across 817 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in internal medicine. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Strizhevsky is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 17 years in practice ▲ 565 Medicare services $9,628 industry payments

Medicare Practice Summary

Medicare Utilization ↗
565
Medicare services
Bottom 34% in NJ for internal medicine
Lower Medicare volume may reflect subspecialty focus, hospital-based work, or a higher share of non-Medicare patients.
330
Unique beneficiaries
$70
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~33 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

Procedure Volume Avg. paid Avg. submitted
Office visit, established patient (30-39 min)
A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition.
302 $98 $564
Blood glucose level test
A test that measures the amount of sugar in your blood.
145 $4 $18
Continuous glucose monitoring with interpretation
This procedure involves monitoring blood sugar levels in tissue fluid using a sensor placed under the skin, along with the interpretation and reporting of the results.
35 $30 $149
Office visit, established patient, complex (40-54 min)
An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter.
32 $147 $798
New patient office visit (45-59 min)
An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter.
19 $104 $729
Office visit, established patient (20-29 min)
An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition.
17 $61 $398
Bone density scan (DEXA)
A test that uses low-dose X-rays to measure bone mineral density in the hip, pelvis, and spine. It helps assess bone strength and risk of fractures.
15 $44 $177
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.

Industry Payment Transparency

Open Payments through 2024 ↗
$9,628
Total received (2018-2024)
Avg $1,375/year across 7 years
Top 8% in NJ for internal medicine
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
44
Companies
817
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$9,401 (97.6%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$227 (2.4%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$1,372
2023
$1,668
2022
$1,701
2021
$1,124
2020
$1,017
2019
$1,598
2018
$1,148

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
Lilly USA, LLC
$397
Amgen Inc.
$226
Mannkind Corporation
$206
RECORDATI_RARE_DISEASES_INC.
$80
Corcept Therapeutics
$76
Boehringer Ingelheim Pharmaceuticals, Inc.
$62
Amneal Pharmaceuticals LLC
$57
Medtronic, Inc.
$53
Novo Nordisk Inc
$50
Abbott Laboratories
$40
Radius Health, Inc.
$40
Neurocrine Biosciences, Inc.
$21
Insulet Corporation
$18
IBSA Pharma Inc.
$16
Amphastar Pharmaceuticals, Inc.
$14
Xeris Pharmaceuticals, Inc.
$14
Top 3 companies account for 60.4% of 2024 payments
All-time payments by company (2018-2024) ›
Lilly USA, LLC
$2,821
Amgen Inc.
$899
Mannkind Corporation
$744
Corcept Therapeutics
$542
Merck Sharp & Dohme Corporation
$503
Abbott Laboratories
$431
Novo Nordisk Inc
$402
MannKind Corporation
$316
AstraZeneca Pharmaceuticals LP
$306
Medtronic, Inc.
$221
Boehringer Ingelheim Pharmaceuticals, Inc.
$213
Dexcom, Inc.
$211
Merck Sharp & Dohme LLC
$200
Amarin Pharma Inc.
$188
SANOFI-AVENTIS U.S. LLC
$177
Amneal Pharmaceuticals LLC
$137
Bayer Healthcare Pharmaceuticals Inc.
$134
Shire North American Group Inc
$126
Radius Health, Inc.
$118
Xeris Pharmaceuticals, Inc.
$113
Insulet Corporation
$93
Medtronic MiniMed, Inc.
$81
RECORDATI_RARE_DISEASES_INC.
$80
VistaPharm, Inc.
$65
Embecta Corp.
$58
IBSA Pharma Inc.
$42
Becton, Dickinson and Company
$42
ABBVIE INC.
$38
Bayer HealthCare Pharmaceuticals Inc.
$32
Valeritas, Inc.
$30
Amryt Pharma Holdings Ltd
$29
Horizon Therapeutics plc
$28
Allergan Inc.
$24
DEXCOM, INC.
$22
Tandem Diabetes Care, Inc.
$22
Neurocrine Biosciences, Inc.
$21
Zealand Pharma US, Inc.
$17
LifeScan, Inc.
$15
AbbVie Inc.
$15
Janssen Pharmaceuticals, Inc
$15
Amphastar Pharmaceuticals, Inc.
$14
Alexion Pharmaceuticals, Inc.
$14
GlaxoSmithKline, LLC.
$14
AbbVie, Inc.
$13
Top 3 companies account for 46.4% of all-time payments
Associated products mentioned in payments ›
AFREZZA · Aimovig · Androgel · BAQSIMI · BASAGLAR · BD Nano 2nd Gen Pen Needle · BD Ultra-Fine · DEXCOM G6 TRANSMITTER · Dexcom G6 Transmitter · EVENITY · FARXIGA · FORTEO · FREESTYLE LIBRE 2 · FREESTYLE LIBRE 3 · FreeStyle Libre · FreeStyle Libre 2 · FreeStyle Lite system · GVOKE HYPOPEN · GVOKE PFS · HUMALOG · HUMULIN · HUMULIN R 500 · INPEN SMART INSULIN DELIVERY SYSTEM · JANUVIA · JARDIANCE · Kerendia · Korlym · LICART · MINIMED 770G · MINIMED 780G · MOUNJARO · MYCAPSSA · Minimed 670G System · NATPARA · NATPARA (PARATHYROID HORMONE) · Omnipod · OneTouch · Ozempic · Prolia · RYBELSUS · Repatha · Rybelsus · SEGLUROMET · SIGNIFOR LAR · SOLIQUA · SOLIQUA 100/33 · STEGLATRO · SYNTHROID · Strensiq · TEPEZZA · TRADJENTA · TRELEGY ELLIPTA · TRULICITY · Thyquidity · Tirosint · Tresiba · Tymlos · UBRELVY · UNITHROID · V-GO · VIBERZI · Vascepa · Victoza · Wegovy · XARELTO · Xultophy 100/3.6 · ZEGALOGUE · t:slim X2 Insulin Pump with Control-IQ
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

Most payments (98%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians. Total industry engagement is in the top 8% for internal medicine in NJ.

Looking for an internal medicine specialist in Lyndhurst?
Compare internal medicine physicians in the Lyndhurst area by procedure volume, costs, and industry payment transparency.
Browse internal medicine physicians nearby

Geographic Context

Internal medicine physicians within 10 mi
10,833
Per 100K population
1134.7
County median income
$123,715
Nearest hospital
CLARA MAASS MEDICAL CENTER
2.5 mi

Data Sources

Provider Registry NPPES Weekly updates
Medicare Enrollment PECOS Monthly updates
Practice Data Medicare Util. Annual (CY lag)
Industry Payments Open Payments CY 2024
Disciplinary History — Not public N/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →

Summary

Dr. Strizhevsky is a clinical cardiology specialist, with moderate Medicare volume, with low-engagement industry engagement in the top 8% of NJ peers, with 17 years of NPI registration.

This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →

Frequently Asked Questions

Is Dr. Strizhevsky experienced with office visit, established patient (30-39 min)?
Based on Medicare claims data, Dr. Strizhevsky performed 302 office visit, established patient (30-39 min) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Strizhevsky receive payments from pharmaceutical companies?
Yes. Dr. Strizhevsky received a total of $9,628 from 44 companies across 817 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Strizhevsky's costs compare to other internal medicine physicians in Lyndhurst?
Dr. Strizhevsky's average Medicare payment per service is $70. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Strizhevsky) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →